Zealand Pharma to Host Conference Call for Q3 Results
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL), a biotechnology company dedicated to developing peptide-based medicines, is excited to announce an upcoming conference call. This event is scheduled for November 7 at 2:00 PM CET (8:00 AM ET), where the company will discuss its financial results for the third quarter and the first nine months of 2024.
Leadership Presentation and Insights
During the call, key members of Zealand Pharma's leadership will present, including Adam Steensberg, the President and CEO; Henriette Wennicke, the CFO; David Kendall, the CMO; and Eric Cox, the CCO. They will deliver valuable insights into the company's performance and discuss its strategy moving forward. Following the presentation, there will be a Q&A session for participants to engage with the leadership team.
Accessing the Conference Call
Participants wishing to listen to the live audio webcast can do so through the company's official platform. They will need to register for the call in advance to receive dial-in information and a unique access PIN. It's recommended to register about 10 minutes prior to the start of the event to ensure a smooth experience. A recording of the call will also be made available afterward, allowing stakeholders to access the insights shared during the call at their convenience.
About Zealand Pharma A/S
Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma specializes in the research and development of innovative peptide-based medicines. To date, over 10 drug candidates developed by the company have proceeded into clinical trials, with two successfully launched on the market. Currently, three candidates are in advanced stages of development. Zealand Pharma collaborates with various pharmaceutical partners to enhance its product offerings and reach more patients. For more information on Zealand Pharma's initiatives and products, visit their official website.
Contact Information
For investor inquiries, Zealand Pharma provides the following contacts:
- Adam Lange, Investor Relations Officer: alange@zealandpharma.com
- Neshat Ahmadi, Investor Relations Manager: neahmadi@zealandpharma.com
- Anna Krassowska, PhD, Vice President, Investor Relations & Corporate Communications: akrassowska@zealandpharma.com
Frequently Asked Questions
What is the date and time of the conference call?
The conference call is scheduled for November 7 at 2 PM CET (8 AM ET).
Who will be presenting during the call?
The call will feature leadership including the CEO, CFO, CMO, and CCO of Zealand Pharma.
How can I listen to the conference call?
You can listen to the call via the company's audio webcast, and registration is required to receive dial-in information.
Is there an opportunity for Q&A?
Yes, after the presentation, there will be a Q&A session where participants can pose questions to the leadership team.
Where can I find the recording of the call?
A recording of the call will be available in the Investor section of Zealand Pharma's official website after the event.
